Physionic

← Physionic15 okt · 9 min

The ‘Berberine Signature’: A New Heart Disease Protection Uncovered!

The ‘Berberine Signature’: A New Heart Disease Protection Uncovered!15 okt9 min

<p><strong>*JOIN THE PHYSIONIC INSIDERS [PREMIUM CONTENT]*</strong>Join the Physionic Insiders: https://bit.ly/PhysionicInsiders2 <strong>*HEALTH AUTONOMY [COURSE]*</strong>Learn to Analyze &amp; Apply Studies for Yourself: https://bit.ly/healthautonomy<strong>*JOIN THE COMMUNITY*</strong>Join my Community [It’s Free!]: https://bit.ly/PhysionicCommunity2<strong>*EMAIL LIST*</strong>1-2 Weekly Email of Value [It’s Free!]: http://bit.ly/2AXIzK6<strong>*HIRE ME FOR CONSULTING:* </strong>Consulting: https://bit.ly/3dmUl2H Created with Biorender0:00 - IntroductionYou talkin’ to me, ApoB?A Berberine Story: Genes, Associations, and TrialsReferences [Funding/Conflicts are provided in the free article (found in the email list and Physionic Community Article Library)][1] Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712–717. doi:10.1016/j.metabol.2008.01.013[Study 1076] Zhao JV, Sarsani V, Chen B, Yun H, Hu J, Liang L. Berberine signature and cardiometabolic diseases using randomized controlled trial, cohort study and Mendelian randomization. npj Cardiovasc Health. 2026;3(1):15. doi:10.1038/s44325-026-00113-w[Study 1077] Zhao JV, Chen B, Chan YH, et al. Sex-specific lipid, apolipoprotein B, and lipoprotein(a) responses to berberine based on 2 randomized placebo-controlled trials. JACC Asia. Published online July 11, 2026. doi:10.1016/j.jacasi.2026.06.011Please use the following link to submit your critique: https://bit.ly/PhysionicCritiqueDisclaimer: None of the information provided by this brand is a replacement for your physician&#39;s advice. This brand is information for the sake of knowledge and the options of choice it provides, not in any way a personalized prescription. Please consult your physician before making any health related changes.</p>